Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 4;14(4):e23806.
doi: 10.7759/cureus.23806. eCollection 2022 Apr.

Nonalcoholic Fatty Liver Disease: Could It Be the Next Medical Tsunami?

Priyanka Bhandari  1 , Amit Sapra  1 , Mohitkumar S Ajmeri  2 , Christine E Albers  3 , Devanshika Sapra  4
Affiliations
Review

Nonalcoholic Fatty Liver Disease: Could It Be the Next Medical Tsunami?

Priyanka Bhandari et al. Cureus. .

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a rapidly increasing cause of chronic liver disease with excess fat deposition in the liver, without an identifiable cause. NAFLD's benign form is called nonalcoholic fatty liver (NAFL), which can progress to nonalcoholic steatohepatitis (NASH) with or without fibrosis. Over time, NASH can progress to cirrhosis and eventually hepatocellular carcinoma (HCC) or progress to HCC without cirrhosis. Its incidence and prevalence are increasing to epidemic proportions, making it the most common cause of chronic liver disease in the western world. This review article attempts to understand the epidemiology, pathophysiology, evaluation, and management, and, most importantly, to generate awareness of this disease process.

Keywords: how common is nash; how is nafld caused; nafld causes; nafld diagnosis; nafld pathophysiology; nafld symptoms; nafld treatment; nafld vs nash; reverse your fatty liver; risk factors for nash.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Prevalence of NAFLD as a percentage of total cases of CLD over time.
The above bar graph depicts the progressive rise in the prevalence of nonalcoholic fatty liver disease (NAFLD) as a cause of chronic liver disease (CLD) in the USA in the last few decades [6].
Figure 2
Figure 2. Associations of nonalcoholic fatty liver disease (NAFLD).
Figure 3
Figure 3. Pathogenesis of nonalcoholic fatty liver disease (NAFLD)
Adapted from [12,13]. TG: triglycerides; FFA: free fatty acid.
Figure 4
Figure 4. Causes of nonalcoholic fatty liver disease (NAFLD) in lean individuals.
PNPLA3: patatin-like phospholipase domain-containing protein 3.
See this image and copyright information in PMC

References

    1. NASH: the emerging most common form of chronic liver disease. Tesfay M, Goldkamp WJ, Neuschwander-Tetri BA. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140162/ Mo Med. 2018;115:225–229. - PMC - PubMed
    1. Pediatric non-alcoholic fatty liver disease. Bush H, Golabi P, Younossi ZM. Children (Basel) 2017;4:48. - PMC - PubMed
    1. Sapra A, Bhandari P. Treasure Island, FL: StatPearls Publishing; 2021. Diabetes Mellitus.
    1. Natural history of nonalcoholic fatty liver disease. Mehta R, Younossi ZM. https://aasldpubs.onlinelibrary.wiley.com/doi/10.1002/cld.27. Clin Liver Dis (Hoboken) 2012;1:112–113. - PMC - PubMed
    1. Epidemiology of non-alcoholic and alcoholic fatty liver diseases. Mitra S, De A, Chowdhury A. Transl Gastroenterol Hepatol. 2020;5:16. - PMC - PubMed

LinkOut - more resources